Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism NOX5 inhibitors(NADPH oxidase 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Italy | 05 Mar 2025 | |
Neurodegenerative Diseases | Preclinical | Italy | 05 Mar 2025 | |
Neuroinflammation | Preclinical | Italy | 05 Mar 2025 |